1)- Pavel Jansa, Grzegorz Kopeć, Adam Torbicki, Roela Sadushi-Kolici, Ioana-Alexandra Campean, Michael Halank, Iveta Simkova, Regina Steringer-Mascherbauer, Barbara Salobir, Walter Klepetko, Jaroslav Lindner, Irene M Lang. The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.Pulmonary circulation. 2023, 13 (3): e12274
2)- Junichi Omura, Kazuki Kitahara, Masashi Takano, Koki Idehara, Seok-Won Kim. Real-world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database.Pulmonary circulation. 2023, 13 (3): e12275
4)- Ben Schneider, Katrina W Kopf, Emma Mason, Maggie Dawson, David Coronado Escobar, Susan M Majka. Microcomputed tomography visualization and quantitation of the pulmonary arterial microvascular tree in mouse models of chronic lung disease.Pulmonary circulation. 2023, 13 (3): e12279
5)- Muhammad R Hadwiono, Anggoro B Hartopo, Widya Wasityastuti, Dyah W Anggrahini, Gusty R T Ryanto, Noriaki Emoto, Lucia K Dinarti. Increased serum activin A level in congenital heart disease-associated pulmonary artery hypertension: A comparative study from the COHARD-PH registry.Pulmonary circulation. 2023, 13 (3): e12280
6)- Mario Naranjo, Erika B Rosenzweig, Anna R Hemnes, Miriam Jacob, Ankit Desai, Nicholas S Hill, A Brett Larive, J Emanuel Finet, Jane Leopold, Evelyn Horn, Robert Frantz, Franz Rischard, Serpil Erzurum, Gerald Beck, Stephen C Mathai, Paul M Hassoun, . Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study.Pulmonary circulation. 2023, 13 (3): e12281
7)- Malini Mahendra, Philip Chu, Elena K Amin, Hythem Nawaytou, James R Duncan, Jeffrey R Fineman, Rebecca Smith-Bindman. Associated radiation exposure from medical imaging and excess lifetime risk of developing cancer in pediatric patients with pulmonary hypertension.Pulmonary circulation. 2023, 13 (3): e12282
8)- Marjorie Patricia George, Hayley D Germack, Amit Goyal, Charlotte Ward, Sean Studer, Sumeet Panjabi. Impact of the COVID-19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension-specific therapy in the United States of America: An observational study.Pulmonary circulation. 2023, 13 (3): e12283
9)- Guillermo Torres, Andrew C Lancaster, Jun Yang, Megan Griffiths, Stephanie Brandal, Rachel Damico, Dhananjay Vaidya, Catherine E Simpson, Lisa J Martin, Michael W Pauciulo, William C Nichols, David D Ivy, Eric D Austin, Paul M Hassoun, Allen D Everett. Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival.Pulmonary circulation. 2023, 13 (3): e12284
10)- Daniel Lachant, Allison Light, Michael Lachant, Jeffrey Annis, Anna Hemnes, Evan Brittain, R James White. Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension.Pulmonary circulation. 2023, 13 (3): e12285
13)- Felipe Kazmirczak, Thenappan Thenappan, Kurt W Prins, Sasha Z Prisco. Sex differences in right ventricular function between Groups 1 and 3 pulmonary hypertension.Pulmonary circulation. 2023, 13 (3): e12288
14)- Elizabeth Colglazier, Angelica J Ng, Claire Parker, David Woolsey, Raymond Holmes, Allison Dsouza, Jasmine Becerra, Leah Stevens, Hythem Nawaytou, Roberta L Keller, Jeffrey R Fineman. Safety and tolerability of continuous inhaled iloprost in critically ill pediatric pulmonary hypertension patients: A retrospective case series.Pulmonary circulation. 2023, 13 (3): e12289